Our Expertise

Our Expertise

At Seattle Cancer Care Alliance (SCCA) in our Pediatric Transplant Program, your child will get the newest therapies from the world’s top experts in pediatric cancers, blood disorders, and transplantation. Forty years ago, we pioneered bone marrow transplantation for children. Today, we are still creating the boldest new treatments for children, such as graft-versus-host-disease (GVHD) prophylaxis and non-myeloablative transplants (mini-transplants), both of which started here.

With every patient, we push for a perfect transplant and follow-up care. And every day, because of our experience, research, and commitment, we inch closer to our goal: a safe procedure, a lifesaving cure, and a long healthy life for every child who comes to us.

At SCCA, your child will receive excellent, world-class medical care in an environment designed to support your child and your entire family. Learn more about the Fred Hutchinson Pediatric Transplant Program at SCCA:

  • We have performed more than 2,300 bone marrow transplants in children and teens; nearly 25 percent of these transplants have been the more difficult unrelated donor transplants. 
  • Every year, we do about 50 bone marrow transplants in children and teens.
  • Our team includes over a dozen physician specialists in pediatric hematology, oncology, and transplantation plus a large staff of pediatric nurse practitioners, pediatric nurses, physician assistants, social workers, dietitians, and other special care providers.
  • Our transplant results are exceptional even though we treat high-risk patients. Overall, 100-day survival for pediatric transplantations done in 2005-2010 was 96, 96, 94, 91, 92, and 100 percent! One-year survival for transplantations done in 2005-2009 was 82, 89, 76, 81, and 78 percent. (See full survival rate details on Seattle Children's website.)
  • We created special techniques for children who lack matched donors; for example, our haploidentical (half-matched) program allows parents and most siblings to donate.
  • SCCA results after unrelated donor transplants are outstanding. We consistently rank among the top U.S. transplant centers in One-year survival rates for these more difficult procedures; in children at SCCA, our recent one-year survival rate was 76 percent after unrelated donor transplant1
  • We offer new procedures to reduce the side effects of conditioning.
  • Our special way of preparing cord blood improves results in stem cell transplants.
  • Increasingly, we use transplants to help children with noncancerous diseases such as immune disorders, blood diseases, and other serious illness.
  • We stay in touch with children and parents long after the transplant. This helps to avoid potential problems and to ensure long-term health.

1NMDP 2011 data